|
||||||||||||||||
| HUM-MOLGEN -> Events -> Courses and Workshops | ||||||||||||||||
| IBC's QA/QC Requirements for the Manufacture and Control of Biopharmaceuticals | ||||||||||||||||
| July 16, 2003 | ||||||||||||||||
|
IBC Life Sciences, The Hilton at Dedham Place, Dedham, MA September 18-19, 2003 This course will cover the FDA regulation and the drug development process, along with the special challenges for QA/QC by biopharmaceuticals; cGMPs for biopharmaceutical APIs; developing an overall QA/QC strategy to manage limited resources from pre-IND through market approval and compliance pressures on biopharmaceutical QA/QC today. While the focus is on FDA expectations for QA/QC, global concerns involving both EMEA and ICH, as appropriate, will also be discussed. |
||||||||||||||||
| Organized by: | IBC Life Sciences | |||||||||||||||
| Invited Speakers: | Course Instructor: John Geigert, Ph.D., President, BioPhamaceutical Quality Solutions |
|||||||||||||||
| Deadline for Abstracts: | - | |||||||||||||||
| Registration: | Phone: (508) 616-5550 Fax: (508) 616-5522 Email: reg@ibcusa.com Online: www.LifeSciencesInfo.com/2896 | |||||||||||||||
| E-mail: | reg@ibcusa.com | |||||||||||||||
| Posted by: | James G. Prudhomme | |||||||||||||||
| Host: | host-65-124-112-226.ibcusa.com | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||